Literature DB >> 8000745

High mortality with systemic lupus erythematosus in hospitalized African blacks.

G M Mody1, K B Parag, B C Nathoo, D J Pudifin, J Duursma, Y K Seedat.   

Abstract

This survey was undertaken to determine the clinical spectrum and outcome of SLE in hospitalized African blacks in Durban, South Africa. We reviewed the hospital records of all patients with SLE who were seen during 1984 and 1990. Eighty-five patients were seen and their mean age at diagnosis was 33.3 years. The prevalence of the various diagnostic criteria was as follows: cutaneous, 68%; arthritis, 66%; renal, 65%; serositis, 29%; neuropsychiatric, 21%; haematological, 71%; immunological, 49%; anti-nuclear factor, 98%. Follow up data were not available in many patients but 25 (29%) are known to have died. The commonest causes of death were renal, infection, neurological and cardiac. This survey shows that SLE is being recognized more frequently in African Blacks and is associated with a high mortality.

Entities:  

Mesh:

Year:  1994        PMID: 8000745     DOI: 10.1093/rheumatology/33.12.1151

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  15 in total

1.  Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus.

Authors:  Keisa W Mathis; Erin B Taylor; Michael J Ryan
Journal:  Pharmacol Res       Date:  2017-04-08       Impact factor: 7.658

2.  Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE.

Authors:  Victoria L Wolf; Taylor L Phillips; Erin B Taylor; Jennifer M Sasser; Michael J Ryan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-24       Impact factor: 4.733

Review 3.  Understanding mechanisms of hypertension in systemic lupus erythematosus.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-03-15

4.  The significance of arterial hypertension at the onset of clinical lupus nephritis.

Authors:  I P Naiker; V Chrystal; I G Randeree; Y K Seedat
Journal:  Postgrad Med J       Date:  1997-04       Impact factor: 2.401

5.  Non-infectious lupus pericarditis: a retrospective hospital-based observation in Yaoundé-Cameroon.

Authors:  Madeleine Singwe Ngandeu; Pierre Ndobo; Cem Gabay
Journal:  Clin Rheumatol       Date:  2009-01-17       Impact factor: 2.980

6.  Pattern of systemic lupus erythematosus among Nigerians.

Authors:  O O Adelowo; S A Oguntona
Journal:  Clin Rheumatol       Date:  2009-02-26       Impact factor: 2.980

7.  Clinical and Serologic Characteristics of Systemic Lupus Erythematosus in the Arab World: A Pooled Analysis of 3,273 Patients.

Authors:  Marwan Adwan
Journal:  Arch Rheumatol       Date:  2018-03-23       Impact factor: 1.472

8.  Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study.

Authors:  J G Hanly; M B Urowitz; L Su; J Sanchez-Guerrero; S C Bae; C Gordon; D J Wallace; D Isenberg; G S Alarcón; J T Merrill; A Clarke; S Bernatsky; M A Dooley; P R Fortin; D Gladman; K Steinsson; M Petri; I N Bruce; S Manzi; M Khamashta; A Zoma; J Font; R Van Vollenhoven; C Aranow; E Ginzler; O Nived; G Sturfelt; R Ramsey-Goldman; K Kalunian; J Douglas; K Qiufen Qi; K Thompson; V Farewell
Journal:  Arthritis Rheum       Date:  2008-05-15

9.  Spectrum of infections and outcome among hospitalized South Africans with systemic lupus erythematosus.

Authors:  Thozama Dubula; Girish M Mody
Journal:  Clin Rheumatol       Date:  2014-12-23       Impact factor: 3.650

10.  Systemic lupus erythematosus in a patient with human immunodeficiency virus infection--challenges in diagnosis and management.

Authors:  T Gould; M Tikly
Journal:  Clin Rheumatol       Date:  2004-02-14       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.